Premier Alternatives

Phagos

Suresnes, France · Founded 2021 · Privately Held (backing)

Operator of a biotechnology research company intended to provide customizable drugs to replace antibiotics in animal farming. Phagos is based in Suresnes, France and was founded in 2021. It was valued at $59.9 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $31.9 million across 1 recorded round; the latest was a $1.5 million seed round in Jul 2022.

PMV mark · valuation
$59.9M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$31.9M
Last round
Seed Round
Jul 2022
How much has Phagos raised?
$31.9Macross 1 recorded rounds · Jul 2022 – Jul 2022

Most recently, Phagos raised $1.5M in its Seed Round (Jul 2022).

Free account
More of Phagos with a free account
  • ·The complete investor list: 26 names
  • ·Watch Phagos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Phagos round by round

1 rounds
Jul 2022Seed Round$1.5MSEC filing▮
7 investors participated

How much has Phagos raised?

Phagos has raised $31.9 million in total; 1 of its rounds is on record. The largest on record was a $1.5 million seed round in Jul 2022.

Phagos has filed 2 Form Ds with the SEC since 2022, most recently in Nov 2024 (null sold to 13 investors).

Phagos investors

26 investors are on record for Phagos, including Bpifrance, Entrepreneurs First, AWS Startups and Agoranov. The seed round in Jul 2022 drew 7 investors.

For fundraisers
Raising for a company like Phagos?

26 investors have backed Phagos.

See all 26 investors →

Frequently asked about Phagos

How much has Phagos raised?
Phagos has raised $31.9M in total across 1 recorded funding rounds.
When was Phagos's last funding round?
Phagos's most recent recorded round was Seed Round in Jul 2022, raising $1.5M.